Orlando Plastic Surgeon Outlines Most Popular Liposuction Treatment Areas
Dr. Jon Paul Trevisani, a top-rated Board-Certified Plastic Surgeon in Orlando, highlights the most popular regions for selective fat removal via liposuction.
ORLANDO, FL, UNITED STATES, March 12, 2025 / EINPresswire.com / -- As cosmetic surgery continues to grow in demand, liposuction has emerged as one of the most frequently performed procedures in the country — even overtaking breast augmentation as the most popular plastic surgery for three years in a row, according to the 2023 Plastic Surgery Statistics Report released by the American Society of Plastic Surgeons. This method of isolated fat removal is considered long-lasting, predictable, and less invasive than comparable body sculpting procedures. One of the primary benefits of liposuction is its versatility and ability to treat virtually any region of the body with natural-looking results.
Some of the most popular treatment sites for liposuction include areas like the neck, abdomen, upper arms, inner thighs, hips, flanks, and mid-back. The region around the neck and chin (often called the submental area) is particularly popular for fat reduction, effectively slimming the appearance of the face and eliminating a 'double chin.' Liposuction to the abdomen and midsection is also a common goal, especially for patients who have had children and want to restore a flatter belly. Dr. Jon Paul Trevisani, founder and lead plastic surgeon at Orlando-based The Aesthetic Surgery Centre, also highlights the upper arms and hips as areas prone to localized fat buildup as the result of aging and pregnancy. Many patients also enlist surgery to smooth common bulges like 'love handles,' 'muffin tops,' or a 'bra bulge.'
Whether you're interested in liposuction to resculpt the face or body, Dr. Jon Paul Trevisani advises scheduling an initial consultation with a board-certified plastic surgeon to learn the full scope of what's possible with selective fat removal. Liposuction can provide powerful results but may not be right for everyone, so it's important to speak with a cosmetic surgeon about your concerns and expectations for the final results.
About Jon Paul Trevisani, MD, FACS
Dr. Jon Paul Trevisani is an aesthetic plastic surgeon who specializes in cosmetic procedures like breast augmentation, tummy tuck surgery, and mastopexy, among other treatment options. Based in the Orlando and Maitland area, Dr. Jon Paul Trevisani has been in practice for 30 years and is featured in several different publications and media outlets, including his distinction as one of 'America's Top Physicians in Plastic Surgery' in the Guide to America's Top Physicians. He is also a Fellow of the American College of Surgeons and an active member of numerous regional and national professional organizations, such as the American Society of Plastic Surgeons (ASPS), the Florida Medical Association, and The Aesthetic Society (ASAPS). Dr. Jon Paul Trevisani is available for interview upon request.
###
The Aesthetic Surgery Centre
413 Lake Howell Rd.
Maitland, FL 32751
(407) 677-8999
Rosemont Media
Katie Nagel
email us here
Legal Disclaimer:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
'Water parasite could cost me sight in one eye'
A woman fears she could partially lose her sight after a water parasite "burrowed" into her eye when she went swimming while wearing contact lenses. Nicola Greenfield, of Rendlesham, Suffolk, has been diagnosed with acanthamoeba keratitis, a painful infection of the cornea - the outer layer that protects the eye. The 58-year-old sought help after her vision became blurred and her right eye started to feel "really sore" and sensitive to light while she was working on her computer. "My vision is incredibly blurred and it feels a bit like getting chilli, lemon juice or bleach in your eye," said Mrs Greenfield, who has had to be signed off work. "The worst case scenario is I lose sight in my right eye and the best case scenario is I lose a little bit – but I am just going to do what I can to try and get better," said Mrs Greenfield. "Since I started treatment it has got a little better, but I am having to wear dark glasses and put blankets against my curtains because I can't bear the light." According to the NHS's Moorfields Eye Hospital website, around two in 100,000 contact lens wearers per year in the UK are diagnosed with acanthamoeba keratitis. The infection is caused by a microscopic organism usually found in bodies of water as well as domestic tap water, swimming pools, hot tubs, soil and air. Some patients can recover within three to six months, while more complicated cases can prove debilitating for as long as a year. Mrs Greenfield was advised to go to Ipswich Hospital after her optician declared she was suffering from a "medical emergency" and needed urgent attention. She has since undergone numerous examinations, biopsies and intensive treatment and has had surgery to remove the top layer of her cornea. "If you wear contact lenses [the parasite] can get trapped behind the lens and start to burrow into the eye," she said. "It is incredibly rare but that, unfortunately, is what's happened to me." Vision Direct says swimming with "contact lenses or getting them wet should be avoided at all times" as doing so can make eyes "vulnerable to contamination by harmful bacteria". Mrs Greenfield, who has worn contact lenses for 40 years, has now warned others to wear goggles and be mindful of purchasing lenses on the internet. "I was always told not to sleep in contact lenses, that was a big no-no, but I don't know why opticians are not telling people not to wear them when they shower or swim," she told the BBC. "Behind the lens is a lovely, warm environment for a germ to breed so people need to be really, really careful. "If I had known then I wouldn't have worn my lenses while swimming." Max Halford, clinical and policy director of the Association of British Dispensing Opticians, said opticians "will always advise on how to handle, clean and replace your contact lenses". "Every UK-based contact lens optician should always provide advice on the correct care and usage of contact lenses both at the initial fitting appointment and at every follow up," he said. "We recommend patients always attend their local opticians for routine contact lenses appointments, usually every 24 months or more often if recommended by your eye care professional. "These appointments are a vital part of your eye health regime if you are a contact lens wearer and they are an opportunity for your optician to review and check the correct procedures are being followed for successful contact lens wear. "Always check with the supplier of your contact lenses that after appointments and advice is available including advice on what to do in an emergency." Follow Suffolk news on BBC Sounds, Facebook, Instagram and X. Woman's eyesight saved by cutting-edge test after mystery infection 'My patients complain about dazzling headlights' 'I never expected I would get to 29 and not see' Moorfields Eye Hospital
Yahoo
7 hours ago
- Yahoo
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
VANCOUVER, British Columbia & TOKYO & WALTHAM, Mass., June 08, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), and Modalis Therapeutics Corporation (TSE 4883; "Modalis"), a CRISPR-based epigenome editing therapeutics company focused on rare genetic diseases, today announced a strategic collaboration to develop an innovative therapy for FSHD, a debilitating muscular disorder affecting approximately 1 million individuals worldwide. The novel therapy leverages Modalis's proprietary CRISPR-GNDM® (Guide Nucleotide-Directed Modulation) technology, which can dynamically modulate gene expression without introducing double-strand DNA breaks. SOLVE FSHD will provide strategic funding to support the development of Modalis's MDL-103 program. MDL-103 is an innovative therapeutic solution that continuously suppresses the expression of the DUX4 gene, the toxic disease-causing gene for FSHD, which becomes abnormally activated due to epigenetic changes in the D4Z4 repeat region on chromosome 4. MDL-103 is designed to have durable activity over long periods of time under the control of a strong, muscle-specific promoter, and is delivered to the muscles of patients using a muscle-tropic AAV delivery system. Modalis's CRISPR-GNDM® technology has the potential to transform the treatment of FSHD by epigenetically silencing the expression of DUX4. "SOLVE FSHD is pleased to partner with Modalis and to add them to our diverse portfolio of collaborators that are advancing potential therapies for FSHD," stated Eva Chin, Executive Director of SOLVE FSHD. "SOLVE FSHD identified Modalis as a company committed to finding a cure for this debilitating condition. We were impressed by their unique approach to targeting the epigenetic cause of FSHD, using a platform technology that has shown promise in other neuromuscular diseases. We believe that the support from SOLVE FSHD will allow Modalis to accelerate the advancement of MDL-103 into clinical trials." "We are delighted to be working in partnership with SOLVE FSHD and greatly appreciate the invaluable support for the development of MDL-103," said Haru Morita, CEO of Modalis. "This strategic collaboration is a strong validation of Modalis's CRISPR-GNDM® technology and our MDL-103 program. As a pioneer in this technology, we have demonstrated promising long-term drug efficacy in mouse models, shown durable target engagement and safety in non-human primates, and exhibited excellent biodistribution in neuromuscular disorders. We believe that MDL-103, which incorporates CRISPR-GNDM® technology with a muscle tropic AAV delivery system, has significant potential as a breakthrough treatment for FSHD." About SOLVE FSHD SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD. Established by renowned Canadian entrepreneur and philanthropist, Chip Wilson, the Wilson family has committed $100 million to kick-start funding into projects that support the organizations' mission to solve FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD, visit About Modalis Therapeutics Corporation Modalis was founded in 2016 and conducts research and development activities in Massachusetts, USA. Modalis is a pioneering leader in the field of epigenetic medicine. Modalis develops therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS diseases, and cardiomyopathies. Modalis's proprietary CRISPR-GNDM® technology is capable of specifically up or down modulating the expression of disease-relevant genes without introducing double-strand DNA breaks. For more information, visit View source version on Contacts SOLVE FSHDAlexandra Grant, House of Wilsonalexandrag@ Modalis Therapeutics CorporationCorporate Planning Departmentmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
17 hours ago
- Associated Press
Where the Sea Meets the Skin: Shapellx Unveils Innovative New OceanHug™ Collection Made from Oyster Shells
ORLANDO, Fla., June 08, 2025 (GLOBE NEWSWIRE) -- Shapellx, a leading women's shapewear brand, proudly announces the launch of OceanHug ™ - a seamless women's wear collection of intimates, outerwear, and shapewear pieces crafted with a first-of-its-kind fabric made from recycled oyster shells. The new sustainable, ocean-inspired collection enhances body contours while delivering the perfect balance of style, comfort, and sustainability. Every year, millions of pounds of oyster shells are discarded, eventually ending up in landfills. Shapellx believes that beauty should never come at the expense of the environment. Every OceanHug™ piece gives new purpose to 33 recycled oyster shells, integrating them into ethically produced, performance-driven fabrics. By turning marine waste into innovation, the collection represents a fresh take on circular fashion by finding a second life for shells that promotes innovation while reducing use of virgin materials. 'As sustainability becomes a top priority for both brands and consumers, Shapellx is proud to lead with innovative materials like oyster protein that combine environmental responsibility with performance-enhancing benefits,' said Shane Shi, Vice President of Shapellx. 'We're committed to delivering more sustainable alternatives without compromising on quality or comfort. OceanHug™ is just the beginning.' The lightweight yet form-fitting OceanHug™ yarn is engineered with breathable, moisture-wicking properties, feeling silky, cool, and comfortable to the touch. The fabric uniquely incorporates collagen peptides and oyster protein fiber, rich in amino acids and trace elements, which can help to nourish the skin and strengthen its barrier. OceanHug™ also offers antibacterial properties, reducing harmful bacteria growth by 2.56%, and is specially processed to be free from irritating chemicals, making it an excellent choice for those with sensitive skin. The new lineup, built with shapewear materials to hug and comfortably embrace the body, comes in soft hues of baby blue, lavender pink, oyster white, and more. The collection includes the following products: To celebrate both the OceanHug™ launch and World Ocean Day on June 8, Shapellx hosted a pop-up event in NoHo, New York. Attendees were able to experience the OceanHug™ fabric firsthand and received a special gift. Designed to suit your everyday life and standout moments, Shapellx's new OceanHug™ collection is available to purchase at To learn more about the collection and keep up with the brand, follow along on Instagram and TikTok. About Shapellx Shapellx is a full-category shapewear brand built on cutting-edge shaping technology and refined design aesthetics. Through premium international retailers such as Nordstrom and its own online platform, Shapellx connects with women who value both quality and style. The brand is dedicated to meeting the dual needs of fashion expression and body contouring in everyday wear, empowering women to radiate confidence from the inside out. Contact: Melina Schaefer [email protected] A video accompanying this announcement is available at
